Skip to main content

ORGANIZACION COMPARTIMENTAL Y TRANSPORTE

BFU2016-81912-REDC

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Redes Investigación /Redes Excelencia
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells

  • Meneses-Salas, Elsa
  • García-Melero, Ana
  • Kanerva, Kristiina
  • Blanco-Muñoz, Patricia
  • Morales-Paytuvi, Frederic
  • Bonjoch, Júlia
  • Casas, Josefina
  • Egert, Antonia
  • Beevi, Syed S.
  • Jose, Jaimy
  • Llorente-Cortés, Vicenta
  • Rye, Kerry-Anne
  • Heeren, Joerg
  • Lu, Albert
  • Pol, Albert
  • Tebar, Francesc
  • Ikonen, Elina
  • Grewal, Thomas
  • Enrich, Carlos
  • Rentero, Carles
Cholesterol accumulation in late endosomes is a prevailing phenotype of Niemann-Pick type C1 (NPC1) mutant cells. Likewise, annexin A6 (AnxA6) overexpression induces a phenotype reminiscent of NPC1 mutant cells. Here, we demonstrate that this cellular cholesterol imbalance is due to AnxA6 promoting Rab7 inactivation via TBC1D15, a Rab7-GAP. In NPC1 mutant cells, AnxA6 depletion and eventual Rab7 activation was associated with peripheral distribution and increased mobility of late endosomes. This was accompanied by an enhanced lipid accumulation in lipid droplets in an acyl-CoA:cholesterol acyltransferase (ACAT)-dependent manner. Moreover, in AnxA6-deficient NPC1 mutant cells, Rab7-mediated rescue of late endosome-cholesterol export required the StAR-related lipid transfer domain-3 (StARD3) protein. Electron microscopy revealed a significant increase of membrane contact sites (MCS) between late endosomes and ER in NPC1 mutant cells lacking AnxA6, suggesting late endosome-cholesterol transfer to the ER via Rab7 and StARD3-dependent MCS formation. This study identifies AnxA6 as a novel gatekeeper that controls cellular distribution of late endosome-cholesterol via regulation of a Rab7-GAP and MCS formation., This study was supported by grants BFU2015-66785-P, Consolider-Ingenio (CSD2009-00016 and BFU2016-81912-REDC) from the Ministerio de Economía y Competitividad (Spain) to CE. TG is supported by the University of Sydney (U7113, RY253, U3367), Sydney, Australia. EI is supported by the Academy of Finland (grants 282192, 307415, 312491) and KK is thankful to grants from the Finnish Cultural Foundation, Häme Regional Fund and University of Helsinki. CR is supported by the Serra Húnter Programme (Generalitat de Catalunya). We thank Dr A.L. Edinger, Dr M. Matsuda, Dr R.J. Youle and Dr C. Bucci for kindly providing cDNA constructs. We are thankful to the staff from Centres Científics i Tecnològics (CCiTUB), Universitat de Barcelona, Campus Casanova, Unitat de Microscòpia Òptica Avançada and Unitat de Microscòpia Electrònica. We are grateful to Maria Molinos (University of Barcelona) and Jennifer Reichardt (School of Pharmacy, University of Sydney) for technical assistance and Mikko Liljeström and Biomedicum Imaging Unit (HiLIFE) for help with live-cell microscopy., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PERK-dependent reciprocal crosstalk between ER and non-centrosomal microtubules coordinates ER architecture and cell shape

  • Sánchez-Álvarez, Miguel
  • Nicolás Lolo, Fidel
  • Sailem, Heba
  • Fulgoni, Giulio
  • Pascual, Patricia
  • Agüera, Lucía
  • Catalá-Montoro, Mauro
  • Arias-García, Mar
  • López, Juan Antonio
  • Vázquez, Jesús
  • Pozo, Miguel Angel
  • Bakal, Chris
The architecture of the endoplasmic reticulum (ER) is a key determinant of its function. Its dynamics are linked to those of the cytoskeleton, but our understanding of how this coordination occurs and what its functional relevance is, limited. Here, we report that the unfolded protein response (UPRER) transducer EIF2AK3/PERK (eukaryotic translation initiation factor 2-alpha kinase 3/protein kinase R-like endoplasmic reticulum kinase) is essential for acute-stress-induced peripheral redistribution and remodeling of the ER through eukaryotic initiation factor 2 alpha (eIF2α) phosphorylation and translation initiation shutdown. PERK-mediated eIF2α phosphorylation can be bypassed by blocking polysome assembly, depleting microtubule (MT)-anchoring ER proteins such as p180/RRBP1 (ribosome-binding protein 1), or disrupting the MT cytoskeleton. Specific disruption of non-centrosomal MTs, but not centrosome depletion, rescues ER redistribution in PERK-deficient cells. Conversely, PERK deficiency stabilizes non-centrosomal MTs against proteasomal degradation, promoting polarized protrusiveness in epithelial cells and neuroblasts. Thus, PERK coordinates ER architecture and homeostasis with cell morphogenesis by coupling ER remodeling and non-centrosomal MT stability and dynamics., Light microscopy and dynamic imaging/ICTS-ReDib at CNIC is supported by MCIN/AEI/10.13039/501100011033 and FEDER “Una manera de hacer Europa” (#ICTS-2018-04-CNIC-16; Madrid, Spain). Amine Sadok and Faraz Mardakheh (former researchers at ICR, London, UK) provided expert advice and assistance with collagen migration experiments. C.B. and H.S. have been beneficiaries of the Wellcome Trust Career Development Fellowship program. Funding support at the C.B. lab was received from the Cancer Research UK (CRUK) Programme Foundation Award (C37275/A20146) and the Stand Up to Cancer campaign. M.S.-A. was a fellow of the COFUND-IPP program (CNIC); is a recipient of grants from the Spanish Ministerio de Ciencia e Innovación (MICINN; RYC2020-029690-I and PID2021-128106NA-I00) and the Scientific Foundation, Spanish Association Against Cancer (LAB AECC 2024 grant LABAE246690SANC); and is supported by consolidation grant CNS2023-144831, sponsored by Ministerio de Ciencia, Innovación y Universidades (MICIU)/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. The M.A.d.P. lab is sponsored by Spanish Ministerio de Ciencia e Innovación (MCNU; PID2020-118658RB-I00, SAF2017-83130-R, and BFU2016-81912-REDC); the Comunidad Autónoma de Madrid/FEDER, Spain (ref. S2018/NMT4443; Actividades de I+D entre Grupos de Investigación en Tecnologías); Obra Social La Caixa (AtheroConvergence-HR20-00075); and the Fundació la Marató de TV3 (385/C/2019). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación y Universidades (MICIU), and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033). The M.S-A. laboratory is a member of the RER-CSIC rare disease research network., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed